Fabry disease in the haemodialysis population: outcome of a UK screening study (SoFAH)

Abstract Background and hypothesis Fabry disease (FD) is an X-linked inherited disorder with an estimated prevalence among the end-stage kidney disease (ESKD) population of 0.3% in men and 0.1% in women [1]. Due to its non-specific manifestations, FD (especially the later-onset variant) is often und...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	K.P. Ng, M. Sandhu, D. Banerjee, J.O. Burton, L. Crowley, T. Doulton, M.A. Hameed, R. Hamer, M. Menon, J. Nicholas, S.B. Ramakrishna, K. Shivakumar, T. Geberhiwot, I. Dasgupta
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2025-05-01
Saila:	BMC Nephrology
Gaiak:	Alpha-galactosidase A Fabry disease GLA variant Hemodialysis Lyso-Gb3
Sarrera elektronikoa:	https://doi.org/10.1186/s12882-025-04127-x
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!